![]() |
市场调查报告书
商品编码
1916514
全球灭菌设备市场:市场规模、占有率、成长率、产业分析、按类型、应用和地区划分的考量因素以及未来预测(2026-2034)Sterilization Equipment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
预计2025年全球灭菌设备市场规模将达77.2亿美元,2026年将成长至80.1亿美元,到2034年将达到115.6亿美元,在预测期(2026-2034年)内,复合年增长率(CAGR)为4.70%。市场成长的主要驱动因素是医院获得性感染 (HAI) 的日益增多、对有效感染控制的需求不断增长以及製药和生物技术研究活动的不断扩大。
灭菌设备广泛应用于医院、专科诊所、製药厂、研究机构和生物製药公司,用于消毒医疗器械、耗材和实验室产品。正确的灭菌在预防诊断和手术过程中因受污染的医疗器械引起的感染方面发挥着至关重要的作用。
医院感染的增加推动了市场需求
医院感染,例如泌尿道感染 (UTI)、手术部位感染和败血症,仍然是全球病患安全面临的重大威胁。根据世界卫生组织 (WHO) 2022 年 5 月发布的数据,高收入国家每 100 名住院患者中就有 7 人,中低收入国家每 100 名住院患者中就有 15 人会在住院期间感染院内感染。令人担忧的是,每 10 名确诊院内感染的患者中就有 1 人死亡,凸显了有效消毒技术的迫切性。
如此高的感染率和死亡率显着增加了对先进消毒系统的需求,例如环氧乙烷 (EO) 消毒器、过氧化氢消毒器和高压蒸气灭菌器。全球医疗机构对感染预防方案日益重视,这持续推动市场扩张。
市场规模与区域趋势
到 2025 年,北美将主导消毒设备市场,占 48.56% 的市场占有率,区域市场价值达 37.5 亿美元。这一主导地位归功于高昂的医疗保健支出、完善的医院基础设施以及旨在减少医院获得性感染 (HAI) 的严格监管准则。预计到 2026 年,美国市场规模将达到 36.7 亿美元,这得益于全国 6,100 多家医院的支持。
欧洲将在 2024 年占据较大占有率,并有望保持稳定成长,这得益于人们对感染控制和监管要求的认识不断提高。德国、英国和法国等国家正积极升级其医院消毒基础设施。
亚太市场预计将以显着的复合年增长率成长,这主要得益于医疗保健基础设施的扩张、对药物研发投入的增加以及人们对传染病认识的提高。中国、印度和日本是主要贡献者,预计到 2026 年,日本的市场规模将达到 20.3 亿美元。
市场区隔洞察
按产品类型划分,化学/气体灭菌器预计将占据市场主导地位,到 2026 年将占据约 72.84% 的市场占有率。此细分市场的主导地位归功于低温灭菌技术的广泛应用,这种技术非常适合对热敏感的医疗器材和聚合物。环氧乙烷和过氧化氢灭菌器广泛应用于医院和医疗器材生产场所。
由于热力灭菌器(包括高压灭菌器)在实验室和研究机构中广泛用于玻璃器皿和实验室设备的灭菌,预计其市场占有率也将增长。
按最终用户划分,医院和专科诊所占据市场主导地位,预计到 2026 年将占市场占有率的 61.36%。手术量大和感染风险增加是推动该领域需求成长的主要因素。同时,在生物製品以及细胞和基因疗法不断发展的推动下,製药和医疗器材製造领域预计将以 10.3% 的复合年增长率高速成长。
技术进步与产业趋势
市场正扩大采用先进的灭菌技术,例如臭氧灭菌、汽化过氧化氢 (VHP) 灭菌和机器人辅助灭菌系统。自动化和自主消毒机器人的应用正在不断扩展,以提高效率、精准度和安全性。
STERIS、Getinge AB、3M、ASP 和 Andersen Sterilizers 等领先企业正透过收购和技术创新持续拓展其产品组合。其中,STERIS 于 2023 年收购 BD 灭菌产品线,Getinge AB 于 2023 年收购 Ultra Clean Systems Inc. 以加强其在北美的市场地位,都是重要的发展动态。
The global sterilization equipment market was valued at USD 7.72 billion in 2025 and is projected to grow to USD 8.01 billion in 2026, reaching USD 11.56 billion by 2034, registering a compound annual growth rate (CAGR) of 4.70% during the forecast period (2026-2034). The market growth is primarily driven by the rising prevalence of hospital-acquired infections (HAIs), increasing demand for effective infection control, and expanding pharmaceutical and biotechnology research activities.
Sterilization equipment is widely used for decontaminating medical instruments, consumables, and laboratory products in hospitals, specialty clinics, pharmaceutical manufacturing facilities, research institutes, and biopharmaceutical companies. Proper sterilization plays a critical role in preventing infections caused by contaminated medical devices during diagnostic and surgical procedures.
Rising Burden of Hospital-Acquired Infections Driving Market Demand
Hospital-acquired infections such as urinary tract infections (UTIs), surgical site infections, and sepsis continue to pose a major threat to patient safety worldwide. According to World Health Organization (WHO) data published in May 2022, 7 out of every 100 patients in high-income countries and 15 out of every 100 patients in low- and middle-income countries acquire HAIs during hospital stays. Alarmingly, 1 in 10 patients diagnosed with HAIs dies, highlighting the urgent need for effective sterilization practices.
Such high infection and mortality rates have significantly increased demand for advanced sterilization systems, including ethylene oxide (EO) sterilizers, hydrogen peroxide sterilizers, and autoclaves. The growing emphasis on infection prevention protocols across healthcare facilities globally continues to support market expansion.
Market Size & Regional Performance
In 2025, North America dominated the sterilization equipment market, accounting for a 48.56% market share, with a regional market value of USD 3.75 billion. The dominance is attributed to high healthcare expenditure, a strong hospital infrastructure, and strict regulatory guidelines aimed at reducing HAIs. The U.S. market is estimated to reach USD 3.67 billion in 2026, supported by over 6,100 hospitals nationwide.
Europe held a substantial share in 2024 and is expected to maintain steady growth due to rising awareness of infection control and regulatory mandates. Countries such as Germany, the U.K., and France are actively upgrading hospital sterilization infrastructure.
The Asia Pacific market is anticipated to grow at a significant CAGR, driven by expanding healthcare infrastructure, increased pharmaceutical R&D investment, and rising awareness of infectious diseases. China, India, and Japan are key contributors, with Japan's market projected to reach USD 2.03 billion in 2026.
Market Segmentation Insights
By product type, chemical/gas sterilizers dominated the market, holding an estimated 72.84% market share in 2026. The segment's dominance is attributed to the widespread use of low-temperature sterilization technologies, which are ideal for heat-sensitive medical devices and polymers. Ethylene oxide and hydrogen peroxide sterilizers are extensively used in hospitals and medical device manufacturing.
Thermal sterilizers, including autoclaves, are also witnessing growth due to their extensive use in laboratories and research institutes for sterilizing glassware and laboratory equipment.
By end user, the hospital & specialty clinic segment led the market and is expected to account for 61.36% of the market share in 2026. The high volume of surgical procedures and increasing infection risk drive demand in this segment. Meanwhile, the pharmaceutical and medical device manufacturers segment is projected to grow at a strong CAGR of 10.3%, supported by rising biologics and cell & gene therapy development.
Technological Advancements and Industry Developments
The market is witnessing increasing adoption of advanced sterilization technologies, such as ozone sterilization, vaporized hydrogen peroxide (VHP), and robotic-assisted sterilization systems. Automation and autonomous disinfection robots are being increasingly deployed to improve efficiency, accuracy, and safety.
Key players including STERIS, Getinge AB, 3M, ASP, and Andersen Sterilizers continue to expand their product portfolios through acquisitions and technological innovation. Notable developments include STERIS' acquisition of BD's sterilization product lines in 2023 and Getinge AB's acquisition of Ultra Clean Systems Inc. in 2023 to strengthen its North American presence.
Conclusion
The global sterilization equipment market is set to witness steady and sustained growth through 2034, driven primarily by the rising burden of hospital-acquired infections, stricter infection prevention regulations, and expanding pharmaceutical and biotechnology research activities. With hospitals and specialty clinics remaining the largest end users, demand for reliable, low-temperature, and high-throughput sterilization systems will continue to rise, particularly for heat-sensitive medical devices and complex surgical instruments. North America will retain market leadership due to advanced healthcare infrastructure and stringent regulatory compliance, while Asia Pacific will emerge as the fastest-growing region supported by healthcare expansion, rising medical device manufacturing, and increased R&D investments. Technological advancements such as vaporized hydrogen peroxide systems, ozone sterilization, and robotic-assisted automation are further enhancing efficiency and safety, making sterilization processes more consistent and scalable. Overall, continuous innovation, regulatory pressure, and growing awareness of patient safety will remain key factors shaping long-term market expansion.
Segmentation By Product Type
By End-user
By Region